AGITG Trial news: The AGITG currently has 17 studies open to recruitment and 11 studies in follow up.
The table below details the AGITG trials that are currently accruing patients.
| Recruited | Target | Date of First Site Open (ANZ) | Number of Sites Open | End of Recruitment | |
| ASCEND (Pancreatic cancer) | 31 | 125 | 13 April 2022 | 13 | October 2023 |
| DYNAMIC-III (Colon cancer) | 918 | 1000 | 09 October 2017 | 43 | December 2023 |
| DYNAMIC-Pancreas (Pancreatic cancer) | 117 | 438 | 01 March 2019 | 26 | August 2023 |
| GENESCREEN 5-FU (Pan Tumour) | 85 | 100 | 1 February 2021 | 4 | April 2025 |
| ICEMELT (Gastrointestinal) | 132 | 200 | 9 December 2020 | 2 | November 2025 |
| INTEGRATE IIb (Gastro-oesophageal cancer) | 245 | 450 | 28 April 2021 | 22 | April 2023 |
| MASTERPLAN (Pancreatic cancer) | 35 | 120 | 01 October 2019 | 11 | October 2023 |
| MASTERPLAN Microbiome (Pancreatic cancer) | 5 | 60 | July 2022 | 2 | February 2024 |
| NEO-IMPACT (Pancreatic cancer) | 2 | 20 | 13 May 2022 | 3 | June 2024 |
| OXTOX (Colorectal cancer) | 17 | 100 | 18 December 2020 | 9 | December 2023 |
| PALEO (Oesophageal cancer) | 4 | 54 | 3 December 2021 | 1 | May 2023 |
| RANDOMS (Pancreatic cancer) | 11 | 60 | 14 December 2020 | 3 | February 2024 |
| RENO (Rectal cancer) | 63 | 125 | 21 January 2019 | 9 | January 2024 |
| RESOLUTE (Colorectal Cancer) | 0 | 75 | 14 December 2021 | 4 | June 2023 |
| RoLaCaRT-1 (Colorectal Cancer) | 26 | 50 | 06 August 2021 | 10 | December 2022 |
| SPAR (Rectal cancer) | 110 | 222 | 13 April 2018 | 15 | December 2022 |
| SSGXXII (Gastro-intestinal Stromal Tumour) | 7 | 25-30 | 17 February 2022 | 8 | March 2023 |